Antiviral therapy can prevent liver cancer in chronic hepatitis B patients
from Health Canal
One of the most severe complications of hepatitis B is the development of liver cancer, which is responsible for approximately 745,000 deaths worldwide each year. Two new studies appearing in the June issue of Gastroenterology provide strong evidence that antiviral therapy can reduce the risk of liver cancer in patients with chronic hepatitis B infection. Gastroenterology is the official journal of the American Gastroenterological Association.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063